• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无机磷酸盐对骨桥蛋白的调节是依赖细胞外信号调节激酶1/2、蛋白激酶C和蛋白酶体的。

Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent.

作者信息

Beck George R, Knecht Nicole

机构信息

National Cancer Institute-Frederick, Center for Cancer Research, Basic Research Laboratory, Bldg. 576 Rm. 110, Frederick, MD 21702, USA.

出版信息

J Biol Chem. 2003 Oct 24;278(43):41921-9. doi: 10.1074/jbc.M304470200. Epub 2003 Aug 13.

DOI:10.1074/jbc.M304470200
PMID:12920127
Abstract

The generation of inorganic phosphate by alkaline phosphatase during osteoblast differentiation represents an important signaling event, although the molecular and cellular consequences are currently undefined. We have previously described osteopontin as a gene regulated by an increase in inorganic phosphate not only in osteoblasts but also in other cell types. We describe here the identification of specific signaling pathways required for the stimulation of osteopontin expression by inorganic phosphate. We have determined that phosphate selectively activates the extracellular signal-regulated kinase (ERK1/2) signaling pathway but does not activate the other mitogen-activated protein kinase signaling proteins, p38, or the c-Jun N-terminal kinase. In addition, our results suggest that cellular exposure to 10 mm inorganic phosphate causes a biphasic ERK1/2 activation. The second ERK1/2 activation is required for osteopontin regulation, whereas the first is not sufficient. Analysis of common protein kinase families has revealed that phosphate-induced osteopontin expression specifically uses a protein kinase C-dependent signaling pathway. In addition, our results suggest that protein kinase C and ERK1/2 are not part of the same pathway but constitute two distinct pathways. Finally, we have determined that the proteasomal activity is required not only for phosphate-induced expression of osteopontin but also for the induction of osteopontin in response to 12-O-tetradecanoylphorbol 13-acetate and okadaic acid. The data presented here define for the first time the ability of increased inorganic phosphate to stimulate specific signaling pathways resulting in functionally significant changes in gene expression and identify three important signaling pathways in the regulation of osteopontin.

摘要

在成骨细胞分化过程中,碱性磷酸酶产生无机磷酸盐代表了一个重要的信号事件,尽管目前其分子和细胞层面的后果尚不清楚。我们之前曾描述骨桥蛋白是一个不仅在成骨细胞中,而且在其他细胞类型中都受无机磷酸盐增加调控的基因。我们在此描述了鉴定无机磷酸盐刺激骨桥蛋白表达所需的特定信号通路。我们已经确定磷酸盐选择性激活细胞外信号调节激酶(ERK1/2)信号通路,但不激活其他丝裂原活化蛋白激酶信号蛋白、p38或c-Jun氨基末端激酶。此外,我们的结果表明细胞暴露于10 mM无机磷酸盐会导致ERK1/2的双相激活。第二次ERK1/2激活是骨桥蛋白调节所必需的,而第一次则不充分。对常见蛋白激酶家族的分析表明,磷酸盐诱导的骨桥蛋白表达特异性地使用了一条依赖蛋白激酶C的信号通路。此外,我们的结果表明蛋白激酶C和ERK1/2不是同一通路的一部分,而是构成两条不同的通路。最后,我们已经确定蛋白酶体活性不仅是磷酸盐诱导骨桥蛋白表达所必需的,也是对12-O-十四烷酰佛波醇-13-乙酸酯和冈田酸响应诱导骨桥蛋白所必需的。此处呈现的数据首次定义了无机磷酸盐增加刺激特定信号通路从而导致基因表达发生功能上显著变化的能力,并确定了骨桥蛋白调节中的三条重要信号通路。

相似文献

1
Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent.无机磷酸盐对骨桥蛋白的调节是依赖细胞外信号调节激酶1/2、蛋白激酶C和蛋白酶体的。
J Biol Chem. 2003 Oct 24;278(43):41921-9. doi: 10.1074/jbc.M304470200. Epub 2003 Aug 13.
2
Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function.Erk1/2在丝氨酸69位点对Bim-EL的磷酸化作用通过蛋白酶体途径促进其降解,并调节其促凋亡功能。
Oncogene. 2003 Oct 2;22(43):6785-93. doi: 10.1038/sj.onc.1206792.
3
Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism.干扰素可激活肝细胞中的p42/44丝裂原活化蛋白激酶以及JAK-STAT(Janus激酶-信号转导子和转录激活子)信号通路:急性乙醇通过蛋白激酶C依赖性机制进行差异调节。
Biochem J. 2000 Jul 15;349(Pt 2):427-34. doi: 10.1042/0264-6021:3490427.
4
Injury-induced osteopontin gene expression in rat arterial smooth muscle cells is dependent on mitogen-activated protein kinases ERK1/ERK2.损伤诱导大鼠动脉平滑肌细胞中骨桥蛋白基因表达依赖于丝裂原活化蛋白激酶ERK1/ERK2。
Arch Biochem Biophys. 2001 Dec 1;396(1):133-7. doi: 10.1006/abbi.2001.2578.
5
Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.细胞外信号调节激酶通路的持续激活可保护细胞免受卟啉介导的光动力疗法的影响。
Cancer Res. 2002 Oct 1;62(19):5528-35.
6
Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity.焦磷酸盐通过与矿物质结合、上调骨桥蛋白并抑制碱性磷酸酶活性来抑制成骨细胞培养物的矿化。
J Biol Chem. 2007 May 25;282(21):15872-83. doi: 10.1074/jbc.M701116200. Epub 2007 Mar 23.
7
Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim.细胞外信号调节激酶1/2(ERK1/2)信号通路的激活促进了仅含BH3结构域的蛋白质Bim的磷酸化及蛋白酶体依赖性降解。
J Biol Chem. 2003 May 23;278(21):18811-6. doi: 10.1074/jbc.M301010200. Epub 2003 Mar 19.
8
ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts.细胞外信号调节激酶1/2(ERK1/2)和应激活化蛋白激酶(JNKs),而非p38激酶,参与了成年大鼠心脏成纤维细胞中活性氧介导的血管紧张素II和白细胞介素-1β诱导骨桥蛋白基因表达的过程。
J Cell Physiol. 2004 Mar;198(3):399-407. doi: 10.1002/jcp.10419.
9
The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2.MEKK1的PHD结构域作为一种E3泛素连接酶,介导ERK1/2的泛素化和降解。
Mol Cell. 2002 May;9(5):945-56. doi: 10.1016/s1097-2765(02)00519-1.
10
Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.显性负性c-Jun(TAM67)靶基因:肿瘤启动子诱导的转化需要HMGA1。
Oncogene. 2004 May 27;23(25):4466-76. doi: 10.1038/sj.onc.1207581.

引用本文的文献

1
Osteoblasts sense extracellular levels of phosphate to control the local expression of phosphatases for matrix mineralisation.成骨细胞感知细胞外磷酸盐水平,以控制用于基质矿化的磷酸酶的局部表达。
Bone Rep. 2025 Jul 30;26:101863. doi: 10.1016/j.bonr.2025.101863. eCollection 2025 Sep.
2
Soft tissue calcifications in chronic kidney disease-beyond the vasculature.慢性肾脏病中的软组织钙化——血管系统之外
Pflugers Arch. 2025 Jun 5. doi: 10.1007/s00424-025-03098-0.
3
Paeonol from attenuates calcification of aortic valvular interstitial cell by inhibiting activation of redox-sensitive NFκB/AKT/ERK1/2 pathway.
丹皮酚通过抑制氧化还原敏感的NFκB/AKT/ERK1/2信号通路激活减轻主动脉瓣间质细胞钙化。
Food Sci Biotechnol. 2025 Feb 20;34(10):2269-2279. doi: 10.1007/s10068-025-01838-7. eCollection 2025 Jun.
4
Second-Generation Antipsychotics Induce Metabolic Disruption in Adipose Tissue-Derived Mesenchymal Stem Cells Through an aPKC-Dependent Pathway.第二代抗精神病药物通过aPKC依赖性途径诱导脂肪组织来源的间充质干细胞发生代谢紊乱。
Cells. 2024 Dec 17;13(24):2084. doi: 10.3390/cells13242084.
5
Chronic Kidney Disease-associated Lung Injury Is Mediated by Phosphate-induced MAPK/AKT Signaling.慢性肾脏病相关肺损伤是由磷酸盐诱导的 MAPK/AKT 信号通路介导的。
Am J Respir Cell Mol Biol. 2024 Dec;71(6):659-676. doi: 10.1165/rcmb.2024-0008OC.
6
An model system based on calcium- and phosphate ion-induced hMSC spheroid mineralization.一种基于钙和磷酸根离子诱导人间充质干细胞球状体矿化的模型系统。
Mater Today Bio. 2023 Nov 7;23:100844. doi: 10.1016/j.mtbio.2023.100844. eCollection 2023 Dec.
7
Dietary phosphorus consumption alters T cell populations, cytokine production, and bone volume in mice.膳食磷的摄入会改变小鼠的 T 细胞群、细胞因子产生和骨量。
JCI Insight. 2023 May 22;8(10):e154729. doi: 10.1172/jci.insight.154729.
8
The Localized Ionic Microenvironment in Bone Modelling/Remodelling: A Potential Guide for the Design of Biomaterials for Bone Tissue Engineering.骨建模/重塑中的局部离子微环境:骨组织工程生物材料设计的潜在指南。
J Funct Biomater. 2023 Jan 19;14(2):56. doi: 10.3390/jfb14020056.
9
Calcium Phosphate-Based Biomaterials for Bone Repair.用于骨修复的磷酸钙基生物材料
J Funct Biomater. 2022 Oct 14;13(4):187. doi: 10.3390/jfb13040187.
10
3D printing of conch-like scaffolds for guiding cell migration and directional bone growth.用于引导细胞迁移和定向骨生长的海螺状支架的3D打印。
Bioact Mater. 2022 Sep 28;22:127-140. doi: 10.1016/j.bioactmat.2022.09.014. eCollection 2023 Apr.